VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $377,000 | -24.9% | 2,120 | -6.2% | 0.04% | -16.3% |
| Q2 2015 | $502,000 | +22.7% | 2,260 | +9.2% | 0.04% | +22.9% |
| Q1 2015 | $409,000 | -12.6% | 2,070 | -36.6% | 0.04% | -5.4% |
| Q4 2014 | $468,000 | +72.1% | 3,263 | +57.6% | 0.04% | +54.2% |
| Q3 2014 | $272,000 | -99.0% | 2,070 | -99.0% | 0.02% | -99.0% |
| Q2 2014 | $27,132,000 | +6.9% | 214,190 | +11.2% | 2.30% | +0.7% |
| Q1 2014 | $25,392,000 | +7.8% | 192,690 | -4.1% | 2.28% | +8.9% |
| Q4 2013 | $23,562,000 | +10.5% | 200,890 | -1.6% | 2.10% | +7.0% |
| Q3 2013 | $21,324,000 | +28.6% | 204,090 | +5.8% | 1.96% | +20.9% |
| Q2 2013 | $16,587,000 | – | 192,960 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |